U.S. markets close in 4 hours 59 minutes

PerkinElmer, Inc. (PKI)

NYSE - Nasdaq Real Time Price. Currency in USD
Add to watchlist
150.39+0.70 (+0.47%)
As of 11:01AM EDT. Market open.
Sign in to post a message.
  • s
    stocktargetadvisor
    $PKI.TO conversation
    $PKI.CA
    Target Up JPMorgan Chase Neutral CAD 52
  • K
    Kermit
    Cenovus Energy Inc.
    Hi-ho, Kermit the Frog here!
    Alberta got its wish for the inclusion of support for large-scale, industrial carbon capture in the federal budget.

    The federal budget documents released Monday include plans for an investment tax credit for carbon capture utilization and storage (CCUS) projects. The technology – which forces carbon-dioxide emissions deep into the ground, keeping them out of the atmosphere – could play a major role in lowering outputs at refineries, cement and fertilizer production plants and power stations across the country. Significantly, it could also help to reduce emissions at Alberta oil sands operations.

    Details of the investment tax credit have yet to be fleshed out. Ottawa says it will move quickly to a 90-day consultation period on the design of the credit, after which it will announce more details, including the rate of the incentive.

    $SU $ENB $IMO $CNQ $TRP $PKI $PPL $
    Bullish
  • Y
    Yahoo Finance Insights
    PerkinElmer is up 5.16% to 134.40
  • B
    Brian
    Why cant this stock stay above the 50 day MA, should have sold at $136 earlier.
  • B
    Brian
    I have concerns with the earnings forecast to decline by an average of 9.2% per year for the next 3 years, also PKI has a high level of debt.
    Bearish
  • M
    Mike
    Hmmmm. Do you think the market will react with the news of the big layoffs this week at PerkinElmer? I heard most of those employees were over 55 years old.
  • S
    Stockguru
    I added today at $151.58. I love the future of this company.
  • J
    Jose
    The state of CA just made a deal with PKI for testing in that state. 150k a day at around $31 a test.
  • F
    Fish
    PKI is growing earnings at 28% and sales growth is 68%. With next years projected growth, market cap is a little over two Xs annual sales. Stock is way undervalued could trade at 250 and not be overvalued!
    Bullish
  • B
    Ben
    New CEO Mr. Singh's first quarterly earning: Not so good. GAAP income low. (It is much easier to manipulate the "adjusted non-GAAP income" to meet analysts' consensus). More importantly, guidance on 2020 revenue and EPS are both lower than analysts' consensus. I guess the stock won't be back at $100+ for the next few months.
  • r
    robert
    This company is undervalued. And it has a decent earnings growth rate. Trailing twelve month PE under 15, EV/EBITDA 10.73, free cash flow yield 8.01%. The recent selloff looks like a buying opportunity to me. It is oversold on the RSI currently. I am going to be taking a position here.
    Bullish
  • p
    p h
    miss due to xchange rates
    strong growth forecast
  • m
    mathew
    SHOULD recover fast CFRA KEEPS BUY OPINION ON SHARES OF PERKIN ELMER, INC.
    7:37 am ET February 3, 2021 (CFRA) Print
    We keep our 12-month target price at $171, 23.9x our 2022 EPS estimate, above PKI's historical forward P/E average. This is justified by improved growth prospects and solid Covid-19 tailwinds. We lift our 2021 EPS estimate by $0.29 to $8.93 as we raise our Q1 EPS estimate to $3.02. We keep our 2022 estimate at $7.16. Q4 EPS of $3.96 vs. $1.35 was a $0.95 robust consensus beat and $1.11 above our estimate. PKI recorded an impressive Q4 top-line revenue of $1.4B (+68% year-over-year), $136M above consensus and $169M above our estimate. Covid-19-related products and solutions contributed $549M in additional revenue (41% of total sales), with PCR tests and extraction solutions generating more than half ($300M). Diagnostics segment revenues (63% of total) recorded an eye-catching 172% organic growth due to record sales in immunodiagnostics and applied genomics. This more than offset the 2% organic decline in Discovery & Analytics segment sales (37% of total) due to continued softness in food and applied markets.
    Bullish
  • S
    Stockguru
    Much better day today. Let’s keep it going.
  • A
    Anthony
    I am hoping PKI benefits from the COVID test kit approval. I am also hoping this COVID-19 Pandemic ends soon
  • U
    UWS44
    $PKI and $GPK . Posted great quarters and have yet to get the benefit in share price.
  • F
    Fatomb
    QUEST & LH need PKI machines and reagents, which are hard to obtain and limit the testing. Other antibody tests are a WILD WILD WEST. See California news etc. about how BAD those antibody tests are. PKI was vetted in the EU and is up 12 dollars for a reason. Watch it cross its 52 week high!!
  • T
    Tom
    Are they allowed to buy shares prior to earnings
  • S
    Stockguru
    Added more under $139 today